Medpace Holdings, Inc.
MEDP- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001668397
In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 699 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Medpace Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 18 filings
- 7 insiders, $176.6M in total
- Insiders trading
- 7
- Net value
- −$176.6M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Medpace Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Troendle August J. | President & CEO | 389,456 | Sep 25, 2026 | 20 |
| Burwig Susan E | Exec. VP, Operations | 65,984 | Sep 17, 2026 | 11 |
| Kraft Robert O. | Director | 955 | Aug 28, 2026 | 8 |
| Brady Kevin M. | CFO & Treasurer | 12,830 | Aug 24, 2026 | 3 |
| Carley Brian T | Director | 27,825 | Aug 21, 2026 | 8 |
| Davenport Fred B Jr | Director | 3,798 | Aug 21, 2026 | 3 |
| McCarthy Cornelius P. III | Director | 12,275 | Aug 13, 2026 | 8 |
| Ewald Stephen P | General Counsel & Corp. Secy. | 20,343 | Jun 1, 2026 | 4 |
| Gwadry-Sridhar Femida H. | Director | – | May 18, 2026 | 1 |
| Zander Dani S. | Director | – | May 18, 2026 | 1 |
| Geiger Jesse J | President | 15,000 | Mar 19, 2026 | 3 |
| Keating Ashley M. | Director | 250 | May 21, 2024 | 0 |
| Medpace Investors, LLC | 10% Owner | 4,733,019 | Mar 8, 2024 | 0 |
| King Tom C | Director | 598 | May 24, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing) | Jul 6-7 | 2 days | Medpace Investors, LLC10% Owner | SSale | −9.30K | $180.46 | −$1.68M | −0.1%6.22M after | 2 lotsDuplicate filing |
| Jul 8, 2021 (view filing) | Jul 6-7 | 2 days | Troendle August J.President & CEO | SSale | −9.30K | $180.46 | −$1.68M | −0.1%6.22M after | 2 lots |
| Jul 6, 2021 (view filing) | Jul 1-2 | 5 days | Troendle August J.President & CEO | SSale | −3.79K | $180.15 | −$683.5K | −0.1%6.23M after | 2 lotsDuplicate filing |
| Jul 6, 2021 (view filing) | Jul 1-2 | 5 days | Medpace Investors, LLC10% Owner | SSale | −3.79K | $180.15 | −$683.5K | −0.1%6.23M after | 2 lots |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Troendle August J.President & CEO | SSale | −4.93K | $181.11 | −$892.1K | −0.1%6.23M after | Duplicate filing |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Medpace Investors, LLC10% Owner | SSale | −4.93K | $181.11 | −$892.1K | −0.1%6.23M after |